The Role of Matrix Metalloproteinase Inhibitors in Ischemia-Reperfusion Injury in the Liver

E-ISSN： 1873-4286|12|23|2923-2934

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.23, 2006-08, pp. : 2923-2934

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Prostaglandins in Liver Ischemia-Reperfusion Injury

Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. : 2935-2951

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Thiols in Liver Ischemia-Reperfusion Injury

Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. : 2891-2901

Bentham Science Publishers

Access to resources Recommend Favorite

The Protective Role of Steroids in Ischemia-Reperfusion Injury of the Liver

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 496-503

Bentham Science Publishers

Access to resources Recommend Favorite

Vinpocetine protects liver against ischemia–reperfusion injury

By Abdelsalam Rania Mohsen

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1064-1070

NRC Research Press

Access to resources Recommend Favorite

Liver ischemia/reperfusion injury: A comparison of the protective effect of the complement inhibitors rsCR1 and C1 inhibitor

By Lehmann T.G. Munch S. Heger M. Klar E. Kirschfink M.

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 21-21

Elsevier

Access to resources Recommend Favorite